Publication | Open Access

Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial

Treatment And PreventionHuman RetrovirusAntiviral TherapyHiv-1 Disease ProgressionDaily AciclovirAntiviral DrugHivChronic Viral InfectionMedicineRandomised Placebo-controlled Trial